Registry for young and middle-aged patients with cerebral small vessel diseases and dementia risk
Official title: Dementia Risk Registry Across the Multidimensional Lifespan: A 10-Year Study(DREAM-10)
Run by Zhejiang Provincial People's Hospital · NCT06164262 · Data updated 2026-11-12
This study is trying to see how small blood vessel problems in the brain affect thinking skills in younger adults aged 30 to 60 who don’t have dementia yet.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 30 Years to 85 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Zhejiang Provincial People's Hospital Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | August 1, 2034 |
| Study ends | December 1, 2034 |
| Registry record updated | September 17, 2026 |
| Trial ID | NCT06164262 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 30 to 60 years with MRI markers indicative of cerebral small vessel diseases and no known dementia.
✕Probably not a fit
Patients with known dementia or other cognitive diseases, as well as those with serious systemic illnesses, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the relationship between cerebral small vessel diseases (CSVD) and cognitive impairment in individuals aged 30 to 60 years who show imaging markers of CSVD but do not have known dementia. Participants will undergo neuropsychological assessments and multimodal MRI scans, along with Optical Coherence Tomography Angiography (OCTA) to evaluate retinal health. The study will collect clinical data and follow participants over time to better understand the progression of cognitive decline in this demographic. By focusing on younger patients, the study seeks to fill a gap in knowledge regarding CSVD's impact on cognitive health.
Why it matters
Potential benefit: If successful, this study could lead to early identification and intervention strategies for dementia in younger individuals with CSVD.
How similar studies have gone: While studies on CSVD and dementia in older populations have shown significant findings, this specific focus on younger patients is relatively novel and less explored.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with any of the CSVD-related MRI imaging markers, including recent small subcortical infarcts, lacunes, white matter hyperintensities, perivascular spaces, microbleeds, and superficial cortical siderosis. 2. Patients aged from 30 to 60 years. 3. Sign informed consent. Exclusion Criteria: 1. Unable to cooperate with inspectors. 2. Known dementia. 3. Other cognitive diseases (such as Alzheimer's disease, Parkinson's disease, or thyroid disease). 4. Serious systemic illness, such as heart, liver, kidney disease or major mental illness. 5. Contraindications for imaging examination. Exit Criteria: 1. Not meet the inclusion criteria. 2. For any poor adherence, not comply with the requirements of the follow-up, or safety reasons determined by investigator. 3. Any adverse or serious adverse events during the study period judged by investigator.
Where it's running
-
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Sheng Zhang, M.D.
- Email: zhangsheng@hmc.edu.cn
- Phone: +8618758188313
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating the relationship between white matter hyperintensity shape and brain clearance in dementia
This study is trying to see how the shape of certain brain changes in older adults with small vessel disease relates to their thinking skills and dementia.
-
Sleep Better, Live Better: a 12-week coaching program to help adults improve sleep and heart-brain health
This trial tests a 12-week, telephone- and text-based sleep coaching program for adults 25–65 with short sleep and higher cardiometabolic risk to see if it improves sleep and related behaviors.
-
Health Ahead: Comparing AI vs. Humans for Preventive Health Screening
This study tests AI-assisted screening interpretation against human-only reads to see if automated screening can match or improve current practice for adults, especially in underserved areas.
-
eHealth prenatal physical activity programme for pregnant women with overweight
This trial will test an eHealth programme to help pregnant women with BMI ≥23 increase physical activity during pregnancy.
-
How a menthol cigarette ban, with or without a quit-smoking campaign, changes what people buy
This trial tests whether banning menthol cigarettes, either alone or paired with a quit-smoking campaign, changes purchasing behavior among adults 21 and older who currently smoke menthol cigarettes.
-
Can QSM MRI help tell MS from age-related brain changes in older adults
This study tests whether an advanced MRI technique called QSM can better differentiate MS-related brain lesions from age-related or small vessel changes in people aged 50–70.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.